Pricing Log in Create free account
Saturday 17 October 2026 Export LFWD’s income statement to Excel — free account

Lifeward Ltd.

LFWD Healthcare Medical Devices

Lifeward Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $22.0 million, down 14.1% from fiscal 2024. In the quarter to June 2026, revenue grew 15.7%, EPS grew 40.8% and free cash flow fell 52.8%, each against the same quarter a year earlier.

6.00 0.06 −0.99%
Market cap
$17.2M
P/E
0.0×
Fwd P/E
−1.4×
Dividend yield
—
F-score
4/9
Altman Z
−18.75
Beneish M
−3.19
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 45.66%

Capital & Financial Ratios $m

Market Cap 17.17
Revenue 21.82
Net Income (30.83)
Free Cash Flow (17.10)
Net Debt (0.94)
Current Ratio 2.33 (at or above 1.5: strong)
Debt/Equity 0.70
P/E ratio 0.00
Fwd P/E (1.35) (negative: loss-making)
P/S ratio 0.77
P/B ratio 1.37
Past 5Y EPS Growth —
This Y EPS Growth 56.92% (at or above 15%: strong)
Next Y EPS Growth 76.32% (at or above 15%: strong)
Next Y revenue growth 14.55% (at or above 10%: strong)
Next 5Y EPS Growth 65.57% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.9×, against a ten-year median of 1.1×; over the ten years it ranged from −6.2× in 2022 to 29.4× in 2016.
P/S against its own 10 years 15.59%
10-year low 10-year high
P/B against its own 10 years 60.70%
10-year low 10-year high
EV/Sales against its own 10 years 30.74%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 28 7 2 9
Receivables 3 6 6 8
Inventory 6 7 6 6
Other — — — 1
39 21 16 26
2023 2024 2025 Q'26
Payables 5 5 6 6
ST’ Debt — — 3 —
Other 2 2 1 2
12 10 12 11

Compound Annual Growth %

10y 5y 3y
Sales 19.39% 38.06% 58.72%
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value (8.71%) (17.33%) (50.22%)

Revenue $m

Mar Jun Sep Dec Year
’26 4 7 — — —
’25 5 6 6 5 22
’24 5 7 6 8 26
’23 1 1 4 7 14
’22 1 2 1 2 6
’21 1 1 2 1 6
’20 1 2 1 1 4
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) (6) — — —
’25 (5) (4) (4) (4) (17)
’24 (8) (6) (4) (4) (22)
’23 (5) (4) (7) (4) (21)
’22 (6) (4) (5) (4) (18)
’21 (3) (3) (3) (3) (11)
’20 (4) (3) (3) (2) (13)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) (6) — — —
’25 (5) (4) (4) (4) (17)
’24 (8) (6) (4) (4) (22)
’23 (5) (4) (7) (5) (21)
’22 (6) (4) (5) (4) (18)
’21 (3) (3) (3) (3) (12)
’20 (4) (3) (3) (2) (13)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (6.70) (4.12) — — —
’25 (5.52) (6.96) (2.40) (3.60) (17.16)
’24 (8.76) (6.00) (4.20) (20.77) (39.98)
’23 (5.88) (6.72) (10.92) (7.91) (31.08)
’22 (5.88) (5.88) (7.56) (7.56) (26.04)
’21 (6.72) (5.88) (5.04) (5.04) (22.68)
’20 (31.08) (18.48) (15.12) (11.76) (68.89)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 5,355.00 2,205.00 338.10 155.40 34.44 97.44 58.80 47.04 16.92 6.01

Analyst estimates 2026–2028

Powerpack
High 33,201.00 7,560.00 2,835.00 846.72 227.64 504.00 110.88 74.76 109.20 48.00
People
People Employees 94 65 58 50 49 51 56 108 80 81
Revenue/emp, $m 0.06 0.12 0.11 0.10 0.09 0.12 0.10 0.13 0.32 0.27
Income, $m
Income, $m Revenue 6 8 7 5 4 6 6 14 26 22
Gross margin, % 12.54 40.00 43.16 55.94 49.83 48.66 34.57 32.14 32.01 38.25
EBT (32) (25) (22) (16) (13) (13) (19) (22) (29) (20)
EBT margin, % (553.76) (317.27) (331.25) (318.98) (294.22) (211.90) (346.62) (159.85) (112.61) (90.63)
Net income (33) (25) (22) (16) (13) (13) (20) (22) (29) (20)
Depreciation 1 1 0 0 0 0 0 2 4 0
Per share, $
Per share, $ Revenue 931.59 807.60 374.00 71.04 23.40 10.46 7.42 19.50 35.43 18.98
Earnings (5,187.52) (2,562.26) (1,239.12) (226.82) (68.89) (22.68) (26.04) (31.08) (39.98) (17.16)
Cash flow (4,370.95) (2,339.79) (844.23) (215.96) (67.07) (20.10) (24.10) (29.08) (29.98) (14.49)
Capex (69.37) (2.19) (0.74) (0.32) (0.39) (0.08) (0.03) (0.11) 0.00 (0.01)
Free cash flow (4,440.32) (2,341.98) (844.97) (216.28) (67.46) (20.18) (24.13) (29.20) (29.98) (14.51)
Book value 1,311.11 386.15 111.14 157.14 116.00 156.65 91.80 65.45 26.02 7.24
Shares, m 0 0 0 0 0 1 1 1 1 1
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S 6.76 2.93 0.98 2.55 4.74 9.88 8.54 3.83 0.59 0.36
P/B 4.81 6.12 3.29 1.15 0.96 0.66 0.69 1.14 0.80 0.96
EV/Sales 5.80 3.03 0.85 0.65 0.47 (4.75) (3.61) 1.96 0.40 0.42
EV/FCF (1.22) (1.04) (0.37) (0.21) (0.16) 2.46 1.11 (1.31) (0.47) (0.55)
Cash, $m
Cash, $m Operating cash flow (28) (22) (15) (15) (13) (11) (18) (21) (22) (17)
Capex 0 0 0 0 0 0 0 0 — 0
Free cash flow (28) (22) (15) (15) (13) (12) (18) (21) (22) (17)
Balance, $m
Balance, $m Working capital 17 11 8 11 21 88 68 27 11 4
Total debt 18 15 9 7 1 1 1 — — 3
Net debt (6) 1 (1) (9) (20) (88) (67) (28) (7) 0
Shareholders’ equity 8 4 2 11 22 89 68 47 19 8
Returns, %
Returns, % ROA (113.38) (90.50) (114.61) (79.07) (49.49) (20.74) (23.16) (32.21) (61.79) (74.60)
ROIC (733.16) (305.99) (1,105.78) (588.47) (360.00) (468.84) (1,433.22) (80.09) (154.06) (139.70)
ROE (222.78) (413.09) (766.99) (244.42) (79.72) (22.92) (24.84) (38.60) (88.56) (146.12)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Lifeward Ltd. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ARAY Accuray Incorporated $20.8M — (loss-making) — (loss-making) −20.87% (below 0%: shrinking) n/m +117.83% (above 0%: growing) 35.22% 5.47% Compare
MODD Modular Medical, Inc. $20.5M — (loss-making) — — n/m −5.61% (below 0%: shrinking) 0.00% 0.00% Compare
PAVM PAVmed Inc. $19.4M — (loss-making) — (loss-making) +450.00% (above 0%: growing) n/m −125.63% (below 0%: shrinking) (269.70%) (21,278.79%) Compare
BDMD Baird Medical Investment Holdings Limited $19.2M — (loss-making) — — n/m −598.12% (below 0%: shrinking) — — Compare
LFWD Lifeward Ltd. $17.2M — (loss-making) — (loss-making) +15.71% (above 0%: growing) n/m −52.77% (below 0%: shrinking) 40.90% (62.69%)
ALUR Allurion Technologies, Inc. $16.7M — (loss-making) — (loss-making) −47.19% (below 0%: shrinking) n/m +65.98% (above 0%: growing) 41.70% (126.60%) Compare
HSCS HeartSciences Inc. $15.4M — (loss-making) — (loss-making) −46.15% (below 0%: shrinking) n/m +18.18% (above 0%: growing) 61.90% (139,957.14%) Compare
IRIX IRIDEX Corporation $14.5M — (loss-making) — (loss-making) −7.41% (below 0%: shrinking) n/m +130.24% (above 0%: growing) 34.19% (8.19%) Compare
RBOT Vicarious Surgical Inc. $14.3M — (loss-making) — — n/m +47.33% (above 0%: growing) 0.00% 0.00% Compare
Median of peers $18.0M — — −20.87% — +32.76% 34.19% (8.19%)

All 149 Medical Devices stocks →

Lifeward Ltd. (LFWD) key facts

  • Concern: Lifeward Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $22.0 million, down 14.1% from fiscal 2024.
  • Lifeward Ltd. (LFWD) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, LFWD traded at $6.00, a market capitalization of $17.2 million.
  • Return on equity was −146.1% and debt-to-equity 0.70.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −18.75 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Lifeward Ltd. (LFWD) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/LFWD · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com